Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery-Reference-Cited by-同舟云学术

Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery

Published:2021-11-15 Issue:11 Volume:2021 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Legg Lynn A¹,Rudberg Ann-Sofie²,Hua Xing³,Wu Simiao³,Hackett Maree L⁴,Tilney Russel⁵,Lindgren Linnea⁶,Kutlubaev Mansur A⁷,Hsieh Cheng-Fang⁸,Barugh Amanda J⁹,Hankey Graeme J¹⁰,Lundström Erik⁶,Dennis Martin¹¹,Mead Gillian E¹¹

Affiliation:

1. NHS Greater Glasgow and Clyde Health Board; Paisley UK

2. Division of Neurology, Department of Clinical Sciences; Karolinska Institutet Danderyd Hospital; Stockholm Sweden

3. Department of Neurology; West China Hospital, Sichuan University; Chengdu China

4. Professor, Program Head, Mental Health; The George Institute for Global Health, Faculty of Medicine, University of New South Wales; Sydney Australia

5. Department of Medicine; Mater Dei Hospital; Msida Malta

6. Department of Neuroscience, Neurology; Uppsala University; Uppsala Sweden

7. Department of Neurology, Neurosurgery and Medical Genetics; Bashkir State Medical University; Ufa Russian Federation

8. Division of Geriatrics and Gerontology, Department of Internal Medicine and Department of Neurology, Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Taiwan

9. Department of Geriatric Medicine; University of Edinburgh; Edinburgh UK

10. Medical School, Faculty of Health and Medical Sciences,; The University of Western Australia; Perth Australia

11. Centre for Clinical Brain Sciences; University of Edinburgh; Edinburgh UK

Publisher

Wiley

Subject

Pharmacology (medical)

Reference219 articles.

1. Serotonergic modulation of brain excitability and motor recovery in patients affected by stroke. A double blind placebo RCT;Acler;International Journal of Stroke,2008

2. A double blind placebo RCT to investigate the effects of serotonergic modulation on brain excitability and motor recovery in stroke patients;Acler;Journal of Neurology,2009

3. Assessment of fluoxetine in stroke recovery (AFFINITY) trial, 2011 www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12611000774921

4. The assessment of fluoxetine in stroke recovery imaging and blood biomarkers sub-study AFFINITY BM www.anzctr.org.au/Trial/Registration/TrialReview.aspx ?ACTRN=12619000986178

5. Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial;AFFINITY Trial Collaboration;Lancet Neurology,2020

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of non-pharmacological therapies for treating post-stroke depression: A systematic review and network meta-analysis;General Hospital Psychiatry;2024-09

2. Are we ready to cure post-stroke cognitive impairment? Many key prerequisites can be achieved quickly and easily;European Stroke Journal;2024-08-11

3. Lifestyle factors as determinants of atherosclerotic cardiovascular health;Atherosclerosis;2024-08

4. The safety and efficacy of escitalopram and sertraline in post-stroke depression: a randomized controlled trial;BMC Psychiatry;2024-05-15

5. What are the effects of pharmacological, non-invasive brain stimulation and psychological interventions, and their combination, in the treatment of post-stroke depression? A Cochrane Review summary with commentary;NeuroRehabilitation;2024-04-24